Long Tail, a Chicago-based AI-driven health system and physician advisory company, has received a strategic investment from Eir Partners Capital.
The company plans to use the funds to grow its operations, develop its services, and expand its business reach. The amount of the deal was not disclosed.
Long Tail, a leading provider of AI-native software and services for utilisation management, physician advisory, and denials and appeals workflows across hospitals and health systems, aims to modernise how providers manage payer complexity by using a data-driven platform that combines proprietary payer intelligence with AI automation to tackle costly claim denials.
Read More:Peachy Receives Minority Investment from Stride Consumer Partners
By leveraging insights from its growing network of providers and physicians, Long Tail delivers actionable payer intelligence that improves reimbursements and streamlines denial workflows. He lowers the costs of utilization and physician advisor programs.
“We are excited to partner with Eir Partners, whose investment validates our vision, strategy, and leadership in the market,” said Jeff Means, CEO and Co-Founder of Long Tail. “Their healthcare technology expertise and operator-led approach make them the perfect partner as we continue to deliver real value to our customers.”
“Utilization management and physician advisory is a complex, underdeveloped market with huge financial impact for health systems,” said Brett Carlson, Founder and CEO of Eir Partners. “We believe Long Tail, led by Jeff, Chris, Austin, and their team, is well-positioned to become a category leader and drive significant growth in this space.”
About Long Tail
Founded in 2023, by Jeff Means, Long Tail provides technology-driven services that help healthcare providers improve operational efficiency by uncovering unpublished payer rules that affect revenue, reducing initial denials, and boosting recovery of clinical denials. The company’s Generative AI engine combines clinical care guidelines, contracts, historical payer behaviour, and other relevant data to determine the precise clinical justification needed for each treatment and service.
About Eir Partners Capital
Founded in 2015 by Brett S. Carlson, Eir Partners Capital is a Miami-based private equity firm specialising in healthcare technology and tech-enabled services. The firm works closely with entrepreneurs and management teams to build scaled, strategically focused platforms across payer, provider, employer, and pharma technology sectors. Eir combines operational expertise with strong industry relationships to create long-term value, investing through growth equity and control buyouts, typically ranging from $40 million to $150 million or more with co-investments.
Read More:Cognichip Raises $60M in Series A Funding
